Cargando…
Immune Responses to Viral Gene Therapy Vectors
Several viral vector-based gene therapy drugs have now received marketing approval. A much larger number of additional viral vectors are in various stages of clinical trials for the treatment of genetic and acquired diseases, with many more in pre-clinical testing. Efficiency of gene transfer and ab...
Autores principales: | Shirley, Jamie L., de Jong, Ype P., Terhorst, Cox, Herzog, Roland W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054714/ https://www.ncbi.nlm.nih.gov/pubmed/31968213 http://dx.doi.org/10.1016/j.ymthe.2020.01.001 |
Ejemplares similares
-
Gene Therapy Research at the Frontiers of Viral Immunology
por: Hoffman, Brad E., et al.
Publicado: (2012) -
Innate Immune Response to Viral Vectors in Gene Therapy
por: Wang, Yixuan, et al.
Publicado: (2023) -
Dynamics of antigen presentation to transgene product-specific CD4(+) T cells and of Treg induction upon hepatic AAV gene transfer
por: Perrin, George Q, et al.
Publicado: (2016) -
Treg: tolerance vs immunity
por: Biswas, Moanaro, et al.
Publicado: (2015) -
Gene Therapy With Regulatory T Cells: A Beneficial Alliance
por: Biswas, Moanaro, et al.
Publicado: (2018)